Geode Capital Management
CELU icon

Geode Capital Management’s Celularity CELU Stock Holding History

Geode Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Sell
167,150
-23,926
-13% -$23K ﹤0.01% 4099
2026
Q1 		$254K Buy
191,076
+30,886
+19% +$39.1K ﹤0.01% 3841
2025
Q4 		$178K Buy
160,190
+20,876
+15% +$37.4K ﹤0.01% 3947
2025
Q3 		$288K Buy
139,314
+4,489
+3% +$12.6K ﹤0.01% 3811
2025
Q2 		$264K Sell
134,825
-1,216
-0.9% -$2.21K ﹤0.01% 3780
2025
Q1 		$235K Buy
136,041
+4,531
+3% +$8.58K ﹤0.01% 3787
2024
Q4 		$274K Sell
131,510
-5,964
-4% -$14.2K ﹤0.01% 3799
2024
Q3 		$408K Sell
137,474
-4,081
-3% -$12K ﹤0.01% 3670
2024
Q2 		$443K Buy
141,555
+6,912
+5% +$24K ﹤0.01% 3605
2024
Q1 		$704K Buy
134,643
+36,832
+38% +$151K ﹤0.01% 3488
2023
Q4 		$242K Hold
97,811
– – ﹤0.01% 3867
2023
Q3 		$217K Buy
97,811
+10,098
+12% +$36.3K ﹤0.01% 3948
2023
Q2 		$467K Sell
87,713
-28,200
-24% -$181K ﹤0.01% 3674
2023
Q1 		$718K Buy
115,913
+668
+0.6% +$5.38K ﹤0.01% 3507
2022
Q4 		$1.49M Buy
115,245
+1,139
+1% +$21K ﹤0.01% 3179
2022
Q3 		$2.63M Buy
114,106
+95,128
+501% +$2.89M ﹤0.01% 2987
2022
Q2 		$645K Buy
18,978
+11,927
+169% +$969K ﹤0.01% 3623
2022
Q1 		$614K Hold
7,051
– – ﹤0.01% 3842
2021
Q4 		$361K Buy
7,051
+396
+6% +$25.3K ﹤0.01% 4209
2021
Q3 		$471K Buy
+6,655
New +$537K ﹤0.01% 4057
2020
Q4 		– Sell
-1,000
Closed -$105K – 4272
2020
Q3 		$105K Buy
+1,000
New +$104K ﹤0.01% 3890

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Geode Capital Management's CELU Position: Q2 2026 in Review

Geode Capital Management reduced its Celularity (CELU) stake by 13% in Q2 2026, selling an estimated $23K and leaving 167,150 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #4099.

Geode Capital Management first reported a position in CELU in Q3 2020 and has held it in 21 quarters since. The position peaked at $2.63M in Q3 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Geode Capital Management held 167,150 shares of Celularity worth $100K as of Q2 2026.
  • Geode Capital Management sold 23,926 Celularity shares in Q2 2026, an estimated $23K.
  • Celularity made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4099 holding.
  • Geode Capital Management first reported a position in Celularity in Q3 2020 and has held it in 21 quarters since.
  • Geode Capital Management's Celularity position peaked at $2.63M in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.